Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

398 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diagnostic and therapeutic challenges.
Gupta OP, Garg SJ, Negrey JN, Jahnle R, Pasion R, Ip MS, Hwang FS, Kaines A, Jain AK, Schwartz SD. Gupta OP, et al. Among authors: ip ms. Retina. 2010 Jun;30(6):975-80. doi: 10.1097/IAE.0b013e3181cd4998. Retina. 2010. PMID: 20531147 No abstract available.
Diagnostic and Therapeutic Challenges.
Prager AJ, Jampol LM, Ip MS. Prager AJ, et al. Among authors: ip ms. Retina. 2021 Mar 1;41(3):665-667. doi: 10.1097/IAE.0000000000002737. Retina. 2021. PMID: 31895072 No abstract available.
Score Study Report 12: Development of venous collaterals in the Score Study.
Weinberg DV, Wahle AE, Ip MS, Scott IU, VanVeldhuisen PC, Blodi BA; SCORE Study Investigator Group. Weinberg DV, et al. Among authors: ip ms. Retina. 2013 Feb;33(2):287-95. doi: 10.1097/IAE.0b013e318263d106. Retina. 2013. PMID: 22972448 Free PMC article. Clinical Trial.
SCORE2 Report 2: Study Design and Baseline Characteristics.
Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Figueroa M, Dugel PU; SCORE2 Investigator Group. Scott IU, et al. Among authors: ip ms. Ophthalmology. 2017 Feb;124(2):245-256. doi: 10.1016/j.ophtha.2016.09.038. Epub 2016 Nov 15. Ophthalmology. 2017. PMID: 27863843 Free PMC article. Clinical Trial.
Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4.
Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, King J, Antoszyk AN, Peters MA, Tolentino M; SCORE2 Investigator Group. Scott IU, et al. Among authors: ip ms. JAMA Ophthalmol. 2017 Jun 1;135(6):639-649. doi: 10.1001/jamaophthalmol.2017.1141. JAMA Ophthalmol. 2017. PMID: 28492860 Free PMC article. Clinical Trial.
Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial.
Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Awh CC, Kunimoto DY, Marcus DM, Wroblewski JJ, King J; SCORE2 Investigator Group. Scott IU, et al. Among authors: ip ms. JAMA. 2017 May 23;317(20):2072-2087. doi: 10.1001/jama.2017.4568. JAMA. 2017. PMID: 28492910 Free PMC article. Clinical Trial.
398 results